Microvast Holdings announces departure of chief financial officer
Investing.com -- The U.S. Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) unveiled a series of actions and programs on Tuesday, aimed at improving the quality, safety, nutritional value and resilience of the domestic supply of infant formula.
The FDA has announced it will start a nutrient review process and ramp up testing for heavy metals and other contaminants in infant formula. Additionally, the agency is urging companies to innovate and create new infant formulas.
U.S. Health Secretary Robert F. Kennedy Jr. stated, "The FDA will use all resources and authorities at its disposal to make sure infant formula products are safe and wholesome for the families and children who rely on them."
The health agency also encourages companies to collaborate with them on any issues related to enhancing transparency and improving labeling clarity. The goal of these initiatives is to ensure that infant formula products meet the highest standards for safety and nutritional adequacy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.